Position in VTRS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$17,303,553
-$126,447 QoQ
Shares Held
1,280,796
-8.5% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 99.99476887810394.ToString("F0")%
Shared 0.ToString("F0")%
None 0.005231121896070881.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MANNING & NAPIER ADVISORS LLC holds $24,582,865 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (70.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
1,280,796 | $17,303,553 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
218,977 | $4,055,454 | |
| 3 | HLN |
Haleon plc
|
306,509 | $3,068,155 | |
| 4 | ZTS |
Zoetis Inc.
|
1,304 | $154,145 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
43 | $1,295 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
2 | $263 |
All Filings in VTRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,303,553 | 1,280,796 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $17,430,000 | 1,400,000 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,504,000 | 960,000 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $8,573,130 | 960,037 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,453,608 | 855,753 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $9,685,240 | 777,931 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $9,755,151 | 840,237 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $9,706,497 | 913,123 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||